707 related articles for article (PubMed ID: 16207545)
1. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
[TBL] [Abstract][Full Text] [Related]
2. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
Baravelli M; Fantoni C; Rogiani S; Farina S; Anzà C; Caltabiano V; Forzani T; Salerno-Uriarte JA
Int J Cardiol; 2007 Sep; 121(1):23-9. PubMed ID: 17188766
[TBL] [Abstract][Full Text] [Related]
3. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
5. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
[TBL] [Abstract][Full Text] [Related]
6. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
7. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
[TBL] [Abstract][Full Text] [Related]
8. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
[TBL] [Abstract][Full Text] [Related]
9. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
Chan PS; Kereiakes DJ; Bartone C; Chow T
Am J Cardiol; 2008 Aug; 102(3):280-4. PubMed ID: 18638586
[TBL] [Abstract][Full Text] [Related]
11. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
[TBL] [Abstract][Full Text] [Related]
12. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
[TBL] [Abstract][Full Text] [Related]
13. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
[TBL] [Abstract][Full Text] [Related]
15. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
16. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
[TBL] [Abstract][Full Text] [Related]
19. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
Rashba EJ; Osman AF; Macmurdy K; Kirk MM; Sarang SE; Peters RW; Shorofsky SR; Gold MR
J Cardiovasc Electrophysiol; 2004 Feb; 15(2):170-6. PubMed ID: 15028046
[TBL] [Abstract][Full Text] [Related]
20. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
Kaufman ES; Bloomfield DM; Steinman RC; Namerow PB; Costantini O; Cohen RJ; Bigger JT
J Am Coll Cardiol; 2006 Oct; 48(7):1399-404. PubMed ID: 17010802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
